HK1085675A1 - Anticancer compounds - Google Patents

Anticancer compounds

Info

Publication number
HK1085675A1
HK1085675A1 HK06107183.6A HK06107183A HK1085675A1 HK 1085675 A1 HK1085675 A1 HK 1085675A1 HK 06107183 A HK06107183 A HK 06107183A HK 1085675 A1 HK1085675 A1 HK 1085675A1
Authority
HK
Hong Kong
Prior art keywords
sub
anticancer compounds
formula
compounds
features
Prior art date
Application number
HK06107183.6A
Other languages
English (en)
Inventor
Qian Shi
Hui-Kang Wang
Masayoshi Oyama
John Robert Vance
Ming S Chen
Original Assignee
Androscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Androscience Corp filed Critical Androscience Corp
Publication of HK1085675A1 publication Critical patent/HK1085675A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HK06107183.6A 2002-10-11 2006-06-24 Anticancer compounds HK1085675A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41778502P 2002-10-11 2002-10-11
PCT/US2003/032547 WO2004033423A2 (en) 2002-10-11 2003-10-14 Anticancer compounds

Publications (1)

Publication Number Publication Date
HK1085675A1 true HK1085675A1 (en) 2006-09-01

Family

ID=32094089

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06107183.6A HK1085675A1 (en) 2002-10-11 2006-06-24 Anticancer compounds

Country Status (9)

Country Link
US (1) US6903133B2 (xx)
EP (1) EP1610790B1 (xx)
JP (1) JP4707393B2 (xx)
AT (1) ATE516031T1 (xx)
AU (1) AU2003300385A1 (xx)
CA (1) CA2501901A1 (xx)
HK (1) HK1085675A1 (xx)
TW (1) TWI307341B (xx)
WO (1) WO2004033423A2 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035661A1 (en) * 2001-10-26 2003-05-01 Centre National De La Recherche Scientifique Derivatives of etoposide and analogs, and pharmaceutical compositions containing them
JP5205967B2 (ja) * 2005-11-07 2013-06-05 日産化学工業株式会社 ヒドラジド化合物及びトロンボポエチンレセプター活性化剤
WO2008136018A2 (en) * 2007-05-03 2008-11-13 Council Of Scientific & Industrial Research 4beta-amin0 podophyllotoxin congeners as potential anticancer agents and a process for the preparation thereof
WO2010052733A1 (en) * 2008-11-07 2010-05-14 Council Of Scientific & Industrial Research NOVEL 4β-AMINO PODOPHVLLOTOXIN CONGENERS AS ANTI TUMOUR ANTIBIOTICS A PROCESS FOR THE PREPARATION THEREOF
CN102757442B (zh) * 2011-04-27 2015-06-24 汤亚杰 硫取代鬼臼类衍生物及其合成方法和应用
CN102757443B (zh) * 2011-04-27 2014-10-29 汤亚杰 硫取代鬼臼类衍生物及其生物转化和分离纯化方法
CN102432622B (zh) * 2011-11-16 2014-07-23 常州大学 4-胺基噁二唑表鬼臼毒素衍生物及其制备方法和用途
CN102603761B (zh) * 2012-02-02 2013-12-25 华东师范大学 含有异羟肟酸结构的表鬼臼毒化合物及制备方法和用途
CN103613600B (zh) * 2013-11-15 2017-01-04 湖北工业大学 具抗肿瘤活性的苯胺基鬼臼类衍生物及其制备方法和用途
CN103613601B (zh) * 2013-11-15 2017-01-11 湖北工业大学 硫取代鬼臼毒素类衍生物及其合成方法和应用
CN103601732A (zh) * 2013-11-15 2014-02-26 湖北工业大学 具抗肿瘤活性的氮取代鬼臼类衍生物及其制备方法和用途
CN103804388B (zh) * 2014-01-29 2016-03-23 中国医学科学院药用植物研究所 4β-氮取代呋喃叔胺类鬼臼毒素衍生物及其制备方法与应用
CN108285455B (zh) * 2017-08-16 2022-02-08 汤亚杰 4β-氨基取代鬼臼毒素类衍生物及其制备方法和应用
CN108285456B (zh) * 2017-09-22 2022-02-08 汤亚杰 4-硫取代鬼臼毒素类衍生物及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366122A3 (en) * 1988-10-26 1991-03-20 Warner-Lambert Company Demethylepipodophyllotoxin derivatives
US5061791A (en) 1988-12-21 1991-10-29 Warner-Lambert Company 4-bromo-4'-demethylepipodophyllotoxin derivatives
US5300500A (en) * 1989-02-23 1994-04-05 The University Of North Carolina At Chapel Hill 4 beta-amino podophyllotoxin analog compounds and methods
US5132322A (en) 1989-02-23 1992-07-21 The University Of North Carolina At Chapel Hill Etoposide analogues
JPH0343802A (ja) * 1989-07-12 1991-02-25 Omron Corp ファジィコントローラ
US5332811A (en) 1989-09-12 1994-07-26 The University Of North Carolina At Chapel Hill Etopside analogs
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW221441B (xx) * 1991-01-25 1994-03-01 Taiho Pharmaceutical Co Ltd
US5338867A (en) 1992-04-24 1994-08-16 Genelabs Technologies, Inc. Preparation of 4β- amino podophyllotoxin compounds
FR2739857B1 (fr) * 1995-10-12 1998-01-02 Pf Medicament Nouveaux derives amines de 2",3"-didesoxyglycosides d'epipodophyllotoxine, leur procede de preparation, leur utilisation comme medicament et leur utilisation destinee aux traitements anticancereux
US6207673B1 (en) * 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
US6051721A (en) 1997-10-02 2000-04-18 The Board Of Regents Of The University Of Nebraska Ring E-modified analogues of(-)-podophyllotoxin and etoposide and a method for their synthesis
US6441198B1 (en) 2000-12-22 2002-08-27 Council Of Scientific And Industrial Research Podophyllotoxin dimer as DNA topoisomerase II inhibitors, and a process for the preparation therefore

Also Published As

Publication number Publication date
JP4707393B2 (ja) 2011-06-22
EP1610790B1 (en) 2011-07-13
AU2003300385A1 (en) 2004-05-04
EP1610790A2 (en) 2006-01-04
WO2004033423A2 (en) 2004-04-22
JP2006503079A (ja) 2006-01-26
US20040138288A1 (en) 2004-07-15
US6903133B2 (en) 2005-06-07
ATE516031T1 (de) 2011-07-15
CA2501901A1 (en) 2004-04-22
WO2004033423A3 (en) 2004-07-29
AU2003300385A8 (en) 2004-05-04
EP1610790A4 (en) 2009-03-25
TWI307341B (en) 2009-03-11
TW200410959A (en) 2004-07-01

Similar Documents

Publication Publication Date Title
HK1085675A1 (en) Anticancer compounds
MY135477A (en) 2-(2,6-dichlorophenyl)-diarylimidazoles
WO2007106192A3 (en) Inhibitors of iap
DE602004021472D1 (en) Pyrimiidinverbindungen
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MY142109A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
HK1079519A1 (en) Furyl compounds
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
MXPA05012837A (es) Inhibidores de caspasa y usos de los mismos.
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
DK1056704T3 (da) Antitumormidler
MXPA04006041A (es) Antivirales de piridoquinoxalina.
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
AU2003290592A1 (en) Antitumor benzoylsulfonamides
WO2004032908A3 (en) Method of inhibiting angiogenesis
IL165259A0 (en) Compounds useful in the treatment of anthraxa and inhibiting lethal factor
DE60225943D1 (de) Topoisomerase-giftmittel
MXPA06000372A (es) Compuestos de silicio y su uso.
DE60201074D1 (en) Pyrazolopyridinderivate
AU2001282238A1 (en) Dihydroporphyrin derivatives and their uses
MXPA04005151A (es) Compuestos terapeuticos.
TW200503672A (en) 2-aminobenzoyl derivatives
WO2003028652A3 (en) Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis
HK1082727A1 (en) 2" oxo-voruscharin and derivatives thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20151014